Enalapril maleate and a lysine analogue (MK‐521): disposition in man.

A new class of angiotensin-converting enzyme inhibitors

1980 • 704 citations

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".

1981 • 189 citations

Disposition of captopril in normal subjects

1980 • 161 citations

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1981 • 146 citations

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.

1981 • 146 citations

The physiological disposition and metabolism of enalapril maleate in laboratory animals.

1982 • 134 citations

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.

1981 • 124 citations

Antihypertensive activity of N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-Ala-L-Pro (MK-421), an orally active converting enzyme inhibitor.

1981 • 119 citations

Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects

2004 • 114 citations

Enalapril maleate and a lysine analogue (MK‐521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.

1982 • 109 citations

Urinary metabolites of 1-(3-Mercapto-2-D-methyl-1-oxopropyl)-L-proline(SQ-14225),a new antihypertensive agent, in rats and dogs.

1981 • 31 citations

Angiotensin Converting Enzyme Activity in Human Serum: Relationship to Enzyme Inhibitor In Vivo and In Vitro

1982 • 22 citations

Absorption and Bioavailability of Captopril in Mice and Rats After Administration by Gavage and in the Diet

1981 • 22 citations

Effect of captopril on proteins and peptide hormones

1981 • 18 citations